Along the same lines, grafts mobilized with pegylated G-CSF were superior to standard G-CSF in that they were associated with less GvHD154,155 while graft-versus-leukemia (GvL) effects were improved through mobilization of invariant natural killer T (iNKT) cells155. The gene discussed is CSF3; the disease is leukemia.